Adenoviral-mediated TGF-β1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis development

This publication has 31 references indexed in Scilit:

• A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-β1 in the development of myelofibrosis
  Blood, 2005
• Modulation of renal glomerular disease using remote delivery of adenoviral‐encoded solubletype II TGF‐β receptor fusion molecule
  The Journal of Gene Medicine, 2003
• Treatment approaches in myelofibrosis with myeloid metaplasia: The old and the new
  Seminars in Hematology, 2003
• Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice
  Blood, 2002
• Anti-sclerotic Effect of Transforming Growth Factor-β Antibody in a Mouse Model of Bleomycin-Induced Scleroderma
  Clinical Immunology, 1999
• TGF-β and Megakaryocytes in the Pathogenesis of Myelofibrosis in Myeloproliferative Disorders
  Leukemia & Lymphoma, 1995
• Transforming growth factor‐β and megakaryocytes in the pathogenesis of idiopathic myelofibrosis
  British Journal of Haematology, 1994
• The Transforming Growth Factor-beta Family
  Annual Review of Cell Biology, 1990
• Transforming growth factor‐β regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts
  British Journal of Haematology, 1989
• Cytogenetics of bone marrow fibroblastic cells in idiopathic chronic myelofibrosis
  British Journal of Haematology, 1987